T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$2.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 3 |
Broadcom
AVGO
|
+$1.61B |
| 4 |
Tesla
TSLA
|
+$1.59B |
| 5 |
Sempra
SRE
|
+$1.26B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.14B |
| 2 |
Amazon
AMZN
|
+$2.54B |
| 3 |
AET
Aetna Inc
AET
|
+$1.44B |
| 4 |
Biogen
BIIB
|
+$1.4B |
| 5 |
Netflix
NFLX
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.6% |
| 2 | Healthcare | 16.34% |
| 3 | Financials | 16.13% |
| 4 | Consumer Discretionary | 14.78% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KAMN
1126
DELISTED
Kaman Corp
KAMN
| $23.9M | ﹤0.01% |
384,197
-167,232
| -30% | -$10.3M |
|
1127
Encompass Health
EHC
$12.3B
| $23.8M | ﹤0.01% |
523,710
+8,849
| +2% | +$379K |
|
1128
ResMed
RMD
$32.8B
| $23.8M | ﹤0.01% |
241,754
-5,453
| -2% | -$515K |
|
|
BID
1129
DELISTED
Sotheby's
BID
| $23.7M | ﹤0.01% |
460,950
+17,574
| +4% | +$895K |
|
1130
ACI Worldwide
ACIW
$5.33B
| $23.6M | ﹤0.01% |
994,642
+23,586
| +2% | +$557K |
|
1131
Ameren
AEE
$30.1B
| $23.5M | ﹤0.01% |
415,390
+6,400
| +2% | +$354K |
|
1132
United Rentals
URI
$70.3B
| $23.5M | ﹤0.01% |
136,149
-1,000
| -0.7% | -$178K |
|
1133
Hawkins
HWKN
$2.67B
| $23.3M | ﹤0.01% |
1,327,502
+446
| +0% | +$7.75K |
|
|
PCSB
1134
DELISTED
PCSB Financial Corporation
PCSB
| $23.3M | ﹤0.01% |
1,112,009
+94,905
| +9% | +$1.9M |
|
1135
Molson Coors Class B
TAP
$7.85B
| $23.3M | ﹤0.01% |
309,169
-5,673
| -2% | -$454K |
|
|
IMGN
1136
DELISTED
Immunogen Inc
IMGN
| $23.2M | ﹤0.01% |
2,209,113
+233,397
| +12% | +$2.31M |
|
1137
Corvus Pharmaceuticals
CRVS
$1.27B
| $23.1M | ﹤0.01% |
2,004,675
+1,698,459
| +555% | +$16.1M |
|
|
HAWK
1138
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $23M | ﹤0.01% |
515,482
-36,864
| -7% | -$1.61M |
|
|
NUVA
1139
DELISTED
NuVasive, Inc.
NUVA
| $23M | ﹤0.01% |
439,769
-3,020
| -0.7% | -$153K |
|
1140
Saia
SAIA
$10.1B
| $22.9M | ﹤0.01% |
304,671
-812,324
| -73% | -$60.4M |
|
|
MZTI
1141
The Marzetti Company
MZTI
$3.18B
| $22.8M | ﹤0.01% |
185,392
-1,274
| -0.7% | -$157K |
|
1142
Quest Diagnostics
DGX
$26.2B
| $22.8M | ﹤0.01% |
227,552
-7,120
| -3% | -$729K |
|
1143
AdvanSix
ASIX
$427M
| $22.6M | ﹤0.01% |
648,501
+65,457
| +11% | +$2.58M |
|
1144
NOV
NOV
$7.45B
| $22.4M | ﹤0.01% |
608,070
-45,900
| -7% | -$1.68M |
|
|
MRO
1145
DELISTED
Marathon Oil Corporation
MRO
| $22.4M | ﹤0.01% |
1,386,217
-10,830
| -0.8% | -$180K |
|
1146
Middlesex Water
MSEX
$1.11B
| $22.3M | ﹤0.01% |
607,914
+208,120
| +52% | +$7.71M |
|
1147
Genuine Parts
GPC
$18.7B
| $22.3M | ﹤0.01% |
248,232
-3,900
| -2% | -$377K |
|
1148
Zumiez
ZUMZ
$318M
| $22.3M | ﹤0.01% |
931,077
-613,609
| -40% | -$13.1M |
|
1149
Celanese
CE
$4.75B
| $22.2M | ﹤0.01% |
221,205
+2,807
| +1% | +$296K |
|
|
CHS
1150
DELISTED
Chicos FAS, Inc.
CHS
| $22.2M | ﹤0.01% |
2,450,555
-3,114,764
| -56% | -$28.9M |
|
Similar funds
T. Rowe Price Associates's Q1 2018 Portfolio in Review
As of Q1 2018, T. Rowe Price Associates held 2,649 positions worth $629B, up 2.1% from $616B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q1 2018 filing shows 91 new, 1,526 increased, 842 reduced and 97 closed positions. Its largest new stake was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M. The largest sale was Apple, an estimated $6.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2018 buy was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M.
- T. Rowe Price Associates added most to Texas Instruments in Q1 2018, an estimated $2.29B increase.
- T. Rowe Price Associates's biggest Q1 2018 reduction was Apple, cutting an estimated $6.14B.
- T. Rowe Price Associates fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $395M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $629B portfolio in Q1 2018.
- T. Rowe Price Associates opened 91 new positions and closed 97 in Q1 2018.
- T. Rowe Price Associates's portfolio value rose 2.1% quarter-over-quarter to $629B.
Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.